109 related articles for article (PubMed ID: 17611572)
1. Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.
Shvidel L; Sigler E; Haran M; Klepfish A; Duek A; Berrebi A; Shtalrid M
Leukemia; 2007 Sep; 21(9):2071-2. PubMed ID: 17611572
[No Abstract] [Full Text] [Related]
2. Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea.
Renso R; Aroldi A; Pioltelli P; Gambacorti-Passerini C; Elli EM
Blood Cancer J; 2018 Jun; 8(6):56. PubMed ID: 29891835
[No Abstract] [Full Text] [Related]
3. Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience.
Begna K; Abdelatif A; Schwager S; Hanson C; Pardanani A; Tefferi A
Blood Cancer J; 2016 May; 6(5):e427. PubMed ID: 27232929
[No Abstract] [Full Text] [Related]
4. Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
Tefferi A; Cerquozzi S; Liaw J
Am J Hematol; 2016 Feb; 91(2):E6-7. PubMed ID: 26587685
[No Abstract] [Full Text] [Related]
5. Outdated dogma? Busulfan, seizure prophylaxis, and stem cell allografting.
Ruiz-Argüelles GJ; Gomez-Almaguer D; Steensma DP
Am J Hematol; 2012 Sep; 87(9):941. PubMed ID: 22674687
[No Abstract] [Full Text] [Related]
6. [Acute myeloid leukemia developing in the course of essential thrombocythemia].
Fernández MC; Gardelegui I; Capote FJ; Gil JL; Muñoz JA
Sangre (Barc); 1996 Oct; 41(5):405-6. PubMed ID: 9026932
[No Abstract] [Full Text] [Related]
7. The treatment of Polycythemia vera and thrombocythemia with myleran (busulphan).
Epstein IS
Isr J Med Sci; 1965 Jul; 1(4):797-9. PubMed ID: 5892718
[No Abstract] [Full Text] [Related]
8. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
Randi ML; Fabris F; Girolami A
Haematologica; 1999 Nov; 84(11):1049-50. PubMed ID: 10553169
[No Abstract] [Full Text] [Related]
9. Is hydroxyurea leukemogenic in essential thrombocythemia?
Tefferi A
Blood; 1998 Aug; 92(4):1459-60; author reply 1460-1. PubMed ID: 9694740
[No Abstract] [Full Text] [Related]
10. [Hyperpigmentation induced by busulfan: a case with ultrastructure examination].
Simonart T; Decaux G; Gourdin JM; Peny MO; Noel JC; Leclercq-Smekens M; De Dobbeleer G
Ann Dermatol Venereol; 1999 May; 126(5):439-40. PubMed ID: 10434109
[No Abstract] [Full Text] [Related]
11. Transition of essential thrombocythemia to megakaryoblastic leukemia after long-term therapy with sequential busulfan, pipobroman and hydroxyurea.
Sironi M; Bertola G; Lodato A; Spinelli M; Sciariada L
Acta Haematol; 2003; 109(3):161-2. PubMed ID: 12714827
[No Abstract] [Full Text] [Related]
12. [Treatment of essential thrombocythemia--personal experience].
Bieniaszewska M; Balon J; Brozek I; Limon J; Hellmann A
Pol Arch Med Wewn; 2000; 103(3-4):179-85. PubMed ID: 11236245
[TBL] [Abstract][Full Text] [Related]
13. [Essential thrombocythemia: conventional therapy].
Grossi A; Vannucchi AM; Longo G; Rafanelli D; Rossi Ferrini P
Haematologica; 1991 Jun; 76 Suppl 3():368-70. PubMed ID: 1752534
[No Abstract] [Full Text] [Related]
14. Autologous stem cell transplantation for elderly patients with acute myeloid leukaemia conditioned with continuous infusion idarubicin and busulphan.
Ferrara F; Palmieri S; Pedata M; Viola A; Izzo T; Criscuolo C; Mele G
Hematol Oncol; 2009 Mar; 27(1):40-5. PubMed ID: 19206083
[TBL] [Abstract][Full Text] [Related]
15. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
Rukavitsyn OA; Pop VP; Seriakov AP
Vopr Onkol; 2004; 50(4):435-9. PubMed ID: 15605767
[TBL] [Abstract][Full Text] [Related]
16. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Boqué C; Grañena A
Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
[No Abstract] [Full Text] [Related]
17. Maintenance chemotherapy with oral treosulfan following first-line treatment in patients with advanced ovarian cancer: feasibility and toxicity.
Meden H; Wittkop Y; Kuhn W
Anticancer Res; 1997; 17(3C):2221-3. PubMed ID: 9216692
[TBL] [Abstract][Full Text] [Related]
18. [Essential thrombocythemia: clinical and laboratory study of 6 cases].
Grebe G; Alvo M; Lira P; Barria C; Mezzano D; Monsalve V
Rev Med Chil; 1983 Dec; 111(12):1248-54. PubMed ID: 6687160
[No Abstract] [Full Text] [Related]
19. Primary thrombocythemia.
Jamshidi K; Ansari A; Windschitl HE; Swaim WR
Geriatrics; 1973 Jan; 28(1):121-33. PubMed ID: 4539498
[No Abstract] [Full Text] [Related]
20. Treosulfan in the treatment of metastatic renal cell carcinoma.
Rigos D; Wechsel HW; Bichler KH
Anticancer Res; 1999; 19(2C):1549-52. PubMed ID: 10365143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]